Initiating and implementing a QI initiative takes time and effort, but a successful program can achieve ideal patient outcomes, reduce costs, and energize a team around a shared purpose. This series of 15- to 30-minute modules offers a foundational review of quality improvement topics as well as some modules related to the care of patients living with type 2 diabetes and obesity. Each module includes a pre- and post-test along with two reinforcement questions throughout the videos. To access and begin each module, click the titles below.
Micromodule Series:
Creating a Diabetes-Focused Aim Statement and Measures
Pharmacotherapy for the Treatment of Type 2 Diabetes and Obesity
SGLT2 Inhibitors and GLP-1 RAs
Data Display for QI: Run Charts
Evidence-Based Interventions in Diabetes Management
Learning Objectives
Upon completion of this activity, learners should be able to:
- Design an appropriate aim statement for a quality improvement project
- Discuss type 2 diabetes pharmacotherapy that goes beyond gluco-centric models
and is patient centered, cardioprotective, and weight centric - Apply guideline recommendations, clinical trial data, and patient preferences to initiate SGLT2 inhibitors and/or GLP-1 receptor agonists for appropriate patients
- Explain the importance of looking at data over time in QI
- Create a run chart to understand variation in your data (common cause and special cause) and determine if your improvement efforts are succeeding
- Differentiate current state assessment tools including process maps, fishbone diagrams, and driver diagrams, and identify when to use each tool
- Describe a clinical intervention that has been shown to result in weight loss for patients who are overweight and/or have diabetes
- Describe how an impact vs effort matrix can help prioritize an intervention
- Identify and apply the key components of the PDSA methodology to making change
Acknowledgment
Provided by Boston University School of Medicine in collaboration with Clinical Care Options, Practicing Clinicians Exchange, and RealCME.
This activity is supported by an educational grant from Lilly.